UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.2106-2110

2018

Volltextzugriff (PDF)

Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-11, Vol.22 (6), p.912-918

2016

Volltextzugriff (PDF)

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

Journal of thrombosis and haemostasis, 2006-02, Vol.4 (2), p.367-371

2006

Volltextzugriff (PDF)

Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.67-76

2017

Volltextzugriff (PDF)

Venous access in haemophilic children: choice and management

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-01, Vol.16 (s1), p.20-24

2010

Volltextzugriff (PDF)

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.e369-e374

2015

Volltextzugriff (PDF)

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.737-743

2010

Volltextzugriff (PDF)

The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.e286-e291

2016

Volltextzugriff (PDF)

Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.e292-e300

2016

Volltextzugriff (PDF)

Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A

Journal of thrombosis and haemostasis, 2016-07, Vol.14 (7), p.1330-1336

2016

Volltextzugriff (PDF)

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.781-790

2012

Volltextzugriff (PDF)

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate

European journal of pharmaceutical sciences, 2020-10, Vol.153, p.105485, Article 105485

2020

Volltextzugriff (PDF)

Muscle function deterioration in patients with haemophilia: Prospective experience from Costa Rica

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.e230-e241

2018

Volltextzugriff (PDF)

Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.598-604

2015

Volltextzugriff (PDF)

Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-05, Vol.16 (3), p.437-446

2010

Volltextzugriff (PDF)

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.691-697

2013

Volltextzugriff (PDF)

Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.589-597

2015

Volltextzugriff (PDF)

Ageing successfully with haemophilia: A multidisciplinary programme

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.57-62

2018

Volltextzugriff (PDF)

Deep intronic variations may cause mild hemophilia A

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1541-1548

2011

Volltextzugriff (PDF)

Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice

Journal of thrombosis and haemostasis, 2008-12, Vol.6 (12), p.2048-2054

2008

Volltextzugriff (PDF)

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.354-360

2016

Volltextzugriff (PDF)

Involvement of the IgE‐basophil system and mild complement activation in haemophilia B with anti‐factor IX neutralizing antibodies and anaphylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.e348-e353

2017

Volltextzugriff (PDF)

Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

Haematologica (Roma), 2019-10, Vol.104 (10), p.2100-2106

2019

Volltextzugriff (PDF)

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1824-1831

2009

Volltextzugriff (PDF)

Polypharmacy in older adults with severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.e1-e3

2018

Volltextzugriff (PDF)

1 – 25 von 1.238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.085)
Mit Volltextzugriff
(938)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH

Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX

Venous access in haemophilic children: choice and management

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile

The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A

Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents

Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate

Muscle function deterioration in patients with haemophilia: Prospective experience from Costa Rica

Factors influencing illness representations and perceived adherence in haemophilic patients: a pilot study

Mortality and causes of death in Italian persons with haemophilia, 1990-2007

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey

Ageing successfully with haemophilia: A multidisciplinary programme

Deep intronic variations may cause mild hemophilia A

Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Involvement of the IgE‐basophil system and mild complement activation in haemophilia B with anti‐factor IX neutralizing antibodies and anaphylaxis

Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A

Polypharmacy in older adults with severe haemophilia

Suchergebnisse filtern